Lung cancer study aims to predict dangerous lung inflammation
NCT ID NCT06192004
First seen May 05, 2026 · Last updated Jun 22, 2026 · Updated 12 times
Summary
This observational study followed 83 people with advanced non-small cell lung cancer who were starting standard treatments. The goal was to gather information to help develop a digital tool that could spot early signs of pneumonitis/ILD, a serious lung inflammation that can occur as a side effect of some cancer drugs. Researchers looked at risk factors and symptoms to improve how this condition is detected and managed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Los Angeles, California, 90027, United States
-
Research Site
Los Angeles, California, 90033, United States
-
Research Site
Denver, Colorado, 80204, United States
-
Research Site
Golden, Colorado, 80222, United States
-
Research Site
Miami Lakes, Florida, 33014, United States
-
Research Site
Skokie, Illinois, 60076, United States
-
Research Site
Ames, Iowa, 50010-3014, United States
-
Research Site
Covington, Louisiana, 70433, United States
-
Research Site
Troy, Michigan, 48098, United States
-
Research Site
Florham Park, New Jersey, 07932, United States
-
Research Site
Mickleton, New Jersey, 08056, United States
-
Research Site
Shirley, New York, 11967, United States
-
Research Site
Westbury, New York, 11590, United States
-
Research Site
Canton, Ohio, 44708, United States
-
Research Site
Canton, Ohio, 44710, United States
-
Research Site
Cincinnati, Ohio, 45219, United States
-
Research Site
Massillon, Ohio, 44646, United States
-
Research Site
York, Pennsylvania, 17403, United States
-
Research Site
Austin, Texas, 78745, United States
-
Research Site
Dallas, Texas, 75246, United States
-
Research Site
Houston, Texas, 77024, United States
-
Research Site
Longview, Texas, 75601, United States
-
Research Site
Odessa, Texas, 79902, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a digital tool that helps doctors identify lung cancer patients at risk of pneumonitis/ILD earlier.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly help patients. The study was terminated early, so results may be limited.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.